METHODS:
Subcutaneous abdominal tissue was obtained from healthy patients of various ages (25-74) undergoing abdominoplasty. ASCs were isolated via standard collagenase protocols. Dermal fibroblasts were isolated from human skin specimens obtained from healthy patients of various ages . Chromatin accessibility profiles were examined using ATAC-seq technology. Genomic nucleosome occupancy was mapped using NucleoATAC software. Pathway enrichment of genes display specific promoter nucleosome positioning was analyzed using Reactome Pathway Database. Small ubiquitin-like modifier (SUMO) protein expression levels at basal and after heat shock were assessed using the dot-blot assay.
RESULTS:
We initially demonstrated that ASC genomes overall contain more peaks from Tn5 fragmentation than those of fibroblasts. Furthermore, we observed that the position of nucleosomes flanking transcription start sites (TSS) is globally well maintained in aging ASCs but not in aging fibroblasts. However, subtle age-dependent changes in nucleosome positioning were detected in the promoter region of genes involved in protein sumoylation pathways in both ASCs and fibroblasts. In ASCs, the nucleosome positions in the promoter region of these genes, especially the one at the upstream of TSS (-1 nucleosome), are more consistently narrowly distributed in the older age group. In contrast, the -1 nucleosome positioning in older fibroblasts is variable. Global SUMO protein expressions under stress and non-stress conditions indicates that SUMO expression in old ASCs is more sensitive to heat shock than in young ASCs, whereas in fibroblasts, this age-dependent sensitivity is minor.
CONCLUSIONS:
Our data suggest a significant role for nucleosome positioning in sumoylation pathway regulation in response to stress during aging of adult stem cells. The distinctive difference in the chromatin structures described here between human ASCs and fibroblasts will contribute to the elucidation of mechanisms regulating gene expression during chronological aging in both stem cells and differentiated cells. The novel findings of age-dependent changes in chromatin structure and regulation of stress response in human ASCs offer significant implications for therapeutic application in regenerative medicine.
METHODS:
As part of an ongoing randomized, controlled crossover trial. Fat was harvested from the abdomen by manual liposuction, processed and injected by Coleman technique, and introduced into the macrochamber fat compartment (MAC) of 7 patients (11 feet) with an average volume of 6.9cc per heel. Patients were offloaded in a customized Darco shoe for 4wks post-operatively. Ultrasound-measured tissue thickness, pedobarograph-measured foot pressures, and Manchester Foot Pain and Disability Index (MFPDI) were obtained pre-operatively and followed for 1 year post-operatively. Outcomes were compared against a randomly selected control group (5 patients) who received standard of care offloading only.
RESULTS:
Average age was 58 years. Average BMI was 30.5. No patients were active smokers or diabetic. When compared to controls, subjects who received fat grafting had significantly greater fat pad thickness at 6 and 12 months both at rest and under load (p<0.05). On pedobarograph, standing heel forces and pressures trended up across all time points while walking heel forces and pressures trended down across all time points. On the MFPDI, patients receiving fat grafting had significantly improved foot pain (p=0.015) and foot appearance (p=0.048) scores at 6 months.
CONCLUSION:
Our current data suggests that fat grafting can restore foot function in patients with heel fat pad atrophy by preserving shock absorbing soft tissue and reducing pain. This has allowed many of our patients to resume previously untolerated activities. However, these findings will need to be corroborated in a larger sample and longer follow up which our ongoing trial aims to provide.
